PUBLISHER: The Business Research Company | PRODUCT CODE: 1939360
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939360
Blood clot retrieval devices are specialized medical tools designed to remove blood clots from blood vessels, particularly in cases of ischemic stroke. They restore normal blood flow by mechanically capturing and extracting the clot. These devices are typically employed in emergency procedures to reduce brain damage and improve patient outcomes.
The primary types of blood clot retrieval devices include mechanical embolus removal devices, Penumbra blood clot retrieval devices, stent retrievers, aspiration devices, and ultrasound-assisted devices. Mechanical embolus removal devices are minimally invasive tools that physically extract blood clots from vessels to rapidly restore blood flow. Technologies used include mechanical thrombectomy, chemical thrombectomy, ultrasound-assisted thrombectomy, and laser-assisted thrombectomy. Applications cover ischemic stroke, hemorrhagic stroke, pulmonary embolism, deep vein thrombosis, transient ischemic attack, and other types of strokes. These devices are applied in coronary arteries, peripheral arteries, and cerebral arteries. Key end users include hospitals, diagnostic centers, specialty clinics, ambulatory surgical centers, and other healthcare facilities.
Tariffs have influenced the blood clot retrieval devices market by increasing costs for imported catheters, stents, and advanced thrombectomy systems, especially in regions like North America, Europe, and Asia-Pacific. Smaller hospitals and diagnostic centers experience adoption delays, while large stroke centers adapt through local sourcing or partnerships. Positive effects include incentives for domestic manufacturing of thrombectomy devices and components, potentially reducing future import dependency and fostering innovation in cost-efficient and portable solutions.
The blood clot retrieval devices market research report is one of a series of new reports from The Business Research Company that provides blood clot retrieval devices market statistics, including blood clot retrieval devices industry global market size, regional shares, competitors with a blood clot retrieval devices market share, detailed blood clot retrieval devices market segments, market trends and opportunities, and any further data you may need to thrive in the blood clot retrieval devices industry. This blood clot retrieval devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The blood clot retrieval devices market size has grown rapidly in recent years. It will grow from $2.37 billion in 2025 to $2.78 billion in 2026 at a compound annual growth rate (CAGR) of 17.5%. The growth in the historic period can be attributed to high incidence of ischemic stroke, limited treatment options, conventional thrombectomy limitations, lack of portable devices, low adoption of imaging-guided procedures.
The blood clot retrieval devices market size is expected to see rapid growth in the next few years. It will grow to $5.25 billion in 2030 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to adoption of ai-assisted devices, growth of minimally invasive techniques, integration of real-time imaging, development of portable thrombectomy systems, expansion of specialty stroke centers globally. Major trends in the forecast period include AI-assisted thrombectomy systems, development of minimally invasive devices, enhanced catheter and stent technology, real-time imaging integration, portable blood clot removal solutions.
The increase in stroke cases is expected to drive growth in the market for blood clot retrieval devices. Stroke occurs when blood flow to part of the brain is blocked or reduced, depriving brain tissue of oxygen and nutrients. This rise in stroke is largely due to an aging population, as older individuals are more prone to hypertension and vascular issues that raise stroke risk. Blood clot retrieval devices assist stroke patients by quickly removing clots blocking brain arteries, restoring circulation and lowering the chance of permanent disability. For example, in May 2024, the Centers for Disease Control and Prevention reported approximately 795,000 strokes annually in the United States. Consequently, the growing number of stroke cases is fueling demand for blood clot retrieval devices.
Leading companies in the blood clot retrieval devices market are developing advanced products such as dual-mechanism thrombectomy systems to enhance clot removal and reduce complications during procedures. These systems combine mechanical extraction and suction techniques within one device to effectively remove both acute and chronic clots, prevent clot migration, and decrease the necessity for multiple treatments. For instance, in March 2025, Inari Medical Inc. introduced the Artix Thrombectomy System, a dual-mechanism arterial thrombectomy device designed for various arterial clots. It integrates aspiration and mechanical extraction in a single operation and includes features such as an over-the-wire mechanical component, a kink-resistant sheath with a low profile, and a covered nitinol mesh funnel to limit clot migration. This device aims to offer doctors enhanced control and flexibility, allowing efficient removal of different clot types while maintaining vessel access throughout the procedure.
In February 2025, Stryker, a medical technology company based in the United States, acquired Inari Medical for an undisclosed sum. This acquisition is intended to broaden Stryker's interventional endovascular portfolio, increase its foothold in the expanding peripheral vascular and venous thromboembolism treatment sectors, and utilize Inari Medical's cutting-edge mechanical thrombectomy technology to improve patient outcomes globally. Inari Medical specializes in blood clot retrieval devices.
Major companies operating in the blood clot retrieval devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Cook Medical LLC, Merit Medical Systems Inc., Penumbra Inc., Surmodics Inc., AngioDynamics Inc., B. Braun Melsungen AG, Acandis GmbH, Phenox GmbH, Rapid Medical Ltd., Argon Medical Devices Inc., Shape Memory Medical Inc., Vesalio Inc.
North America was the largest region in the blood clot retrieval devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood clot retrieval devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the blood clot retrieval devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The blood clot retrieval devices market consists of revenues earned by entities by providing services such as manufacturing and supplying clot retrieval devices, offering clinical training and procedural support, conducting research and technological innovation, assisting with regulatory approvals and market access. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood clot retrieval devices market also includes sales of mechanical thrombectomy devices, aspiration catheters, and stent retrievers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Blood Clot Retrieval Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses blood clot retrieval devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for blood clot retrieval devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood clot retrieval devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.